These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8215954)

  • 21. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
    Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzymes produced by autoactivation of blood factor XII in buffer: A contribution from the Hematology at Biomaterial Interfaces Research Group.
    Golas A; Pitakjakpipop H; Rahn MS; Siedlecki CA; Vogler EA
    Biomaterials; 2015 Jan; 37():1-12. PubMed ID: 25443791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contact activation of blood-plasma coagulation.
    Vogler EA; Siedlecki CA
    Biomaterials; 2009 Apr; 30(10):1857-69. PubMed ID: 19168215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation.
    Ivanov I; Matafonov A; Sun MF; Cheng Q; Dickeson SK; Verhamme IM; Emsley J; Gailani D
    Blood; 2017 Mar; 129(11):1527-1537. PubMed ID: 28069606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-chain factor XII: a new form of activated factor XII.
    Ivanov I; Matafonov A; Gailani D
    Curr Opin Hematol; 2017 Sep; 24(5):411-418. PubMed ID: 28604413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
    Schousboe I
    Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma.
    Wuillemin WA; Furlan M; Stricker H; Lämmle B
    Thromb Haemost; 1992 Feb; 67(2):219-25. PubMed ID: 1621242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioactive heparin surfaces from derivatization of polyacrylamide-grafted LLDPE.
    Wirsén A; Ohrlander M; Albertsson AC
    Biomaterials; 1996 Oct; 17(19):1881-9. PubMed ID: 8889068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice.
    Vorlova S; Koch M; Manthey HD; Cochain C; Busch M; Chaudhari SM; Stegner D; Yepes M; Lorenz K; Nolte MW; Nieswandt B; Zernecke A
    Thromb Haemost; 2017 Jan; 117(1):176-187. PubMed ID: 27786338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tackling the Root Cause of Surface-Induced Coagulation: Inhibition of FXII Activation to Mitigate Coagulation Propagation and Prevent Clotting.
    Witzdam L; Vosberg B; Große-Berkenbusch K; Stoppelkamp S; Wendel HP; Rodriguez-Emmenegger C
    Macromol Biosci; 2024 Feb; 24(2):e2300321. PubMed ID: 37742317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach.
    Citarella F; te Velthuis H; Helmer-Citterich M; Hack CE
    Thromb Haemost; 2000 Dec; 84(6):1057-65. PubMed ID: 11154114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet surface-associated activation and secretion-mediated inhibition of coagulation factor XII.
    Zakharova NV; Artemenko EO; Podoplelova NA; Sveshnikova AN; Demina IA; Ataullakhanov FI; Panteleev MA
    PLoS One; 2015; 10(2):e0116665. PubMed ID: 25688860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III.
    Pixley RA; Schapira M; Colman RW
    Blood; 1985 Jul; 66(1):198-203. PubMed ID: 3873967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nanobody-based method for tracking factor XII activation in plasma.
    de Maat S; van Dooremalen S; de Groot PG; Maas C
    Thromb Haemost; 2013 Sep; 110(3):458-68. PubMed ID: 23349032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contact activation of blood plasma and factor XII by ion-exchange resins.
    Josh Yeh CH; Dimachkie ZO; Golas A; Cheng A; Parhi P; Vogler EA
    Biomaterials; 2012 Jan; 33(1):9-19. PubMed ID: 21982294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ordered adsorption of coagulation factor XII on negatively charged polymer surfaces probed by sum frequency generation vibrational spectroscopy.
    Chen X; Wang J; Paszti Z; Wang F; Schrauben JN; Tarabara VV; Schmaier AH; Chen Z
    Anal Bioanal Chem; 2007 May; 388(1):65-72. PubMed ID: 17205260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor.
    Esnouf MP; Burgess AI; Dodds AW; Sarphie AF; Miller GJ
    Thromb Haemost; 2000 Jun; 83(6):874-81. PubMed ID: 10896241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
    Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of IgG for the activity of factor XII measured in human plasma.
    Briseid K; Hoem NO; Johannesen S; Vangen AM; Westgaard T
    Scand J Clin Lab Invest; 1996 Dec; 56(8):725-34. PubMed ID: 9034354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoactivation of blood factor XII at hydrophilic and hydrophobic surfaces.
    Zhuo R; Siedlecki CA; Vogler EA
    Biomaterials; 2006 Aug; 27(24):4325-32. PubMed ID: 16644008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.